Synthesis and Biological Evaluation of Novel Asymmetric (E)-3-(4-(Benzyloxy) Phenyl)-2-((Substituted Benzylidene) Amino)-1-(Thiazolidin-3-yl) Propan-1-One and Computational Validation by Molecular Docking and QSTR Studies

References

• Y. Hu, Z. Xu, S. Zhang, Wu Xiang, D. Jun-Wei, Lv Zao-Sheng, and F. Lian-Shun, “Recent Developments of Coumarin-Containing Derivatives and Their Anti-Tubercular Activity,” European Journal of Medicinal Chemistry 136 (2017): 122–30. doi:10.1016/j.ejmech.2017.05.004.
   PubMed Web of Science ®Google Scholar
• S. Musrat, S. Ayushi, S. Jay, A. Dinesh, and A. Shikha, “Saturated Five-Membered Thiazolidines and Their Derivatives: From Synthesis to Biological Applications,” Topics in Current Chemistry 378, no. 2 (2020): 1–90.
   Web of Science ®Google Scholar
• M. Nasr, M. Gineinah, and E. El-Bendary, “Synthesis and In Vitro Antibacterial Evaluation of Novel Imidazo[2',1':5,1]-1,2,4-Triazolo[4,3-c]-Quinazoline Derivatives Of 5-Thioxo-1, 2, 4-Triazole, 4-Oxothiazolidine, and Their Open-Chain Counterparts,” Archiv Der Pharmazie 336, no. 12 (2003): 560–6. doi:10.1002/ardp.200300809.
   PubMed Web of Science ®Google Scholar
• B. Belleau, L. Brasili, L. Chan, M. DiMarco, B. Zacharie, N. Nguyen-Ba, H. Jenkinson, J. Coates, and J. Cameron, “A Novel Class of 1, 3-Oxathiolane Nucleoside Analogues Having Potent Anti-HIV Activity,” Bioorganic & Medicinal Chemistry Letters 3, no. 8 (1993): 1723–8. doi:10.1016/S0960-894X(00)80050-5.
   Web of Science ®Google Scholar
• M. Peterson and R. Vince, “Synthesis and Biological Evaluation of 4-Purinylpyrrolidine Nucleosides,” Journal of Medicinal Chemistry 34, no. 9 (1991): 2787–97. doi:10.1021/jm00113a017.
   PubMed Web of Science ®Google Scholar
• K. Obydennov, A. Khamidullina, A. Galushchinskiy, A. Shatunova, M. Kosterina, T. Kalinina, Z. Fan, T. Glukhareva, and Y. Morzherin, “Discovery of Methyl (5 Z)-[2-(2,4,5-Trioxopyrrolidin-3-ylidene)-4-Oxo-1,3-Thiazolidin-5-Ylidene]Acetates as Antifungal Agents against Potato Diseases,” Journal of Agricultural and Food Chemistry 66, no. 24 (2018): 6239–45. doi:10.1021/acs.jafc.8b02151.
   PubMed Web of Science ®Google Scholar
• V. Solomon, W. Haq, K. Srivastava, S. Puri, and B. Katti, “Synthesis and Antimalarial Activity of Side Chain Modified 4-Aminoquinoline Derivatives,” Journal of Medicinal Chemistry 50, no. 2 (2007): 394–8. doi:10.1021/jm061002i.
   PubMed Web of Science ®Google Scholar
• M. Barreca, A. Chimirri, L. Luca, A. Monforte, P. Monforte, A. Rao, M. Zappala, J. Balzarini, E. Clercq, C. Pannecouque, et al. “Discovery of 2,3-Diaryl-1,3-Thiazolidin-4-Ones as Potent Anti-HIV-1 Agents,” Bioorganic & Medicinal Chemistry Letters 11, no. 13 (2001): 1793–6. doi:10.1016/S0960-894X(01)00304-3.
   PubMed Web of Science ®Google Scholar
• N. Fuloria, V. Singh, M. Shaharyar, and M. Ali, “Synthesis, Characterization and Biological Studies of New Schiff Bases and Azetidinone Derived from Propionic Acid Derivatives,” Asian Journal of Chemistry. 20, no. 8 (2008): 6457–62.
   Google Scholar
• G. Kucukguzel, A. Kocatepe, E. Clercq, F. Sahin, and M. Gulluce, “Synthesis and Biological Activity of 4-Thiazolidinones, Thiosemicarbazides Derived from Diflunisal Hydrazide,” European Journal of Medicinal Chemistry 41, no. 3 (2006): 353–9. doi:10.1016/j.ejmech.2005.11.005.
   PubMed Web of Science ®Google Scholar
• Ş. G. Küçükgüzel, E. E. Oruç, S. Rollas, F. Şahin, and A. Özbek, “Synthesis, Characterization and Biological Activity of Novel 4-Thiazolidinones, 1,3,4-Oxadiazoles and Some Related Compounds,” European Journal of Medicinal Chemistry 37, no. 3 (2002): 197–206. doi:10.1016/S0223-5234(01)01326-5.
   PubMed Web of Science ®Google Scholar
• P. Vicini, A. Geronikaki, K. Anastasia, M. Incerti, and F. Zani, “Cyclobutane Derivatives as Potent NK1 Selective Antagonists,” Bioorganic & Medicinal Chemistry Letters 16, no. 14 (2006): 3859–64.
   PubMed Web of Science ®Google Scholar
• K. V. G. C. Sekhar, V. S. Rao, A. S. Reddy, R. Sunandini, and V. S. A. Kumar Satuluri, “Solvent Free Microwave Accelerated Synthesis of Heterocyclic Thiazolidin-4-Ones as Anti-Microbial and Anti-Fungal Agents,” Bulletin of the Korean Chemical Society 31, no. 5 (2010): 1219–22. doi:10.5012/bkcs.2010.31.5.1219.
   Web of Science ®Google Scholar
• B. M. Gurupadayya, M. Gopal, B. Padmashali, and Y. N. Manohara, “Synthesis and Pharmacological Evaluation of Azetidin-2-Ones and Thiazolidin-4-Ones Encompassing Benzothiazole,” Indian Journal of Pharmaceutical Sciences 70, no. 5 (2008): 572–7. doi:10.4103/0250-474X.45393.
   PubMed Web of Science ®Google Scholar
• D. Visagaperumal, K. Jaya, R. Vijayaraj, and N. Anbalgan, “Microwave Induced Synthesis of Some New 3-Substituted-1,3-Thiazolidin-4-Ones for Their Potent Anti-Microbial and Antitubercular Activities,” International Journal of ChemTech Research 1, no. 4 (2009): 1048–51.
   Google Scholar
• J. East, A. Kennedy, J. Tomsig, A. De Leon, K. Lynch, and T. Macdonald, “Synthesis and Structure-Activity Relationships of Tyrosine-Based Inhibitors of Autotaxin (ATX),” Bioorganic & Medicinal Chemistry Letters 20, no. 23 (2010): 7132–6. doi:10.1016/j.bmcl.2010.09.030.
   PubMed Web of Science ®Google Scholar
• J. Cobb, S. Blanchard, E. Boswell, K. Brown, P. Charifson, J. Cooper, J. Collins, M. Dezube, B. Henke, E. Hull-Ryde, et al. “ N-(2-Benzoylphenyl)-L-Tyrosine PPARgamma Agonists. 3. Structure-Activity Relationship and Optimization of the N-Aryl Substituent,” Journal of Medicinal Chemistry 41, no. 25 (1998): 5055–69. doi:10.1021/jm980414r.
   PubMed Web of Science ®Google Scholar
• A. Pund, S. Saboo, G. Sonawane, A. Dukale, and B. Magare, “Synthesis of 2,5-Disubstituted-1,3,4-Thiadiazole Derivatives from (2S)-3-(Benzyloxy)-2-[(Tert-Butoxycarbonyl)Amino] Propanoic Acid and Evaluation of Anti-Microbial Activity,” Synthetic Communications 50, no. 24 (2020): 3854–64. doi:10.1080/00397911.2020.1817488.
   Web of Science ®Google Scholar
• B. Kahveci, O. Bekircan, and S. Karaoglu, “Synthesis and Anti-Microbial Activity of Some 3-Alkyl-4-(Arylmethyleneamino)-4,5-Dihydro-1H-1,2,4-Triazol-5-Ones,” Indian Journal of Chemistry 40, no. B (2005): 2614–7.
   Google Scholar
• O. Bekircan, B. Kahveci, and M. Kucuk, “Synthesis and Anticancer Evaluation of Some New Unsymmetrical 3,5-Diaryl-4H-1,2,4-Triazole Derivatives,” Turkish Journal of Chemistry 30 (2006): 29–40.
   Web of Science ®Google Scholar
• M. Singh, and C. Dash, “Synthesis of Some New Schiff Bases Containing Thiazole and Oxazole Nuclei and Their Fungicidal Activity,” Pesticides 22, no. 11 (1988): 33–7.
   Google Scholar
• S. Holla, K. Shivananda, S. Shenoy, and G. Antony, “Studies on Aryl Furan Derivatives: Part VII. Synthesis and Characterization of Some Mannich Bases Carrying Halophenylfuryl Moieties as Promising Antibacterial Agents,” Farmaco 53 (1998): 531–5.
   PubMedGoogle Scholar
• S. Holla, B. Veerendra, K. Shivananda, and B. Poojary, “Synthesis Characterization and Anticancer Activity Studies on Some Mannich Bases Derived from 1,2,4-Triazoles,” European Journal of Medicinal Chemistry 38, no. 7–8 (2003): 759–67. doi:10.1016/S0223-5234(03)00128-4.
   PubMed Web of Science ®Google Scholar
• E. Gokce, G. Bakir, F. Sahin, E. Kupeli, and E. Yesilada, “Synthesis of New Mannich Bases of Arylpyridazinones as Analgesic and Anti-Inflammatory Agents,” Arzneimittel Forschung 55 (2005): 318–25.
   PubMed Web of Science ®Google Scholar
• R. Dimmock, S. Jonnalagadda, A. Phillips, E. Erciyas, K. Shyam, and A. Semple, “Anticonvulsant Properties of Some Mannich Bases of Conjugated Arylidene Ketones,” Journal of Pharmaceutical Sciences 81, no. 5 (1992): 436–40. doi:10.1002/jps.2600810509.
   PubMed Web of Science ®Google Scholar
• F. Lopes, R. Capela, J. O. Gonçaves, P. N. Horton, M. B. Hursthouse, J. Iley, C. M. Casimiro, J. Bom, and R. Moreira, “Amidomethylation of Amodiaquine: Antimalarial N-Mannich Base Derivatives,” Tetrahedron Letters 45, no. 41 (2004): 7663–6. doi:10.1016/j.tetlet.2004.08.093.
   Web of Science ®Google Scholar
• J. Knabe, P. Buch, and W. Schmit, “Derivatives of Barbituric Acid Cytostatic and CNS Activities of Chiral Barbiturate Mannich-Bases,” Archiv Der Pharmazie 316, no. 12 (1983): 1051–3. doi:10.1002/ardp.19833161216.
   PubMed Web of Science ®Google Scholar
• R. Islam, J. Abedin, M. Hossain, and H. Duddeck, “Synthesis of 1-Methyl Bis-Dioxopyrolino [2,3:2,3:2,3:6,5] Benzene and Its Heterocycles via Thiocarbohydrazone, Thiosemicarbazone,” Journal of the Bangladesh Chemical Society 11 (1998): 71–8.
   Google Scholar
• E. Michel, H. John, and T. Elizabeth, “FAP Inhibitors,” (WO2007085895A2, filed August 31, 2006, and issued August 02, 2007).
   Google Scholar
• N. Andersen, J. Cadahia, V. Previtali, J. Bondebjerg, C. Hansen, A. Hansen, T. Andresen, and M. Clausen, “Methotrexate Prodrugs Sensitive to Reactive Oxygen Species for the Improved Treatment of Rheumatoid Arthritis,” European Journal of Medicinal Chemistry 156 (2018): 738–46. doi:10.1016/j.ejmech.2018.07.045.
   PubMed Web of Science ®Google Scholar
• C. Decicco and P. Grover, “Total Asymmetric Synthesis of the Potent Immunosuppressive Marine Natural Product Microcolin A,” The Journal of Organic Chemistry 61, no. 10 (1996): 3534–41. doi:10.1021/jo952123l.
   Web of Science ®Google Scholar
• N. Kumar, S. Devineni, K. Aggile, P. Gajjala, P. Kumar, and S. Dubey, “Facile New Industrial Process for Synthesis of Teneligliptin through New Intermediates and Its Optimization with Control of Impurities,” Research on Chemical Intermediates 44, no. 1 (2018): 567–84. doi:10.1007/s11164-017-3120-3.
   Web of Science ®Google Scholar
• T. Yoshida, F. Akahoshi, H. Sakashita, H. Kitajima, M. Nakamura, S. Sonda, M. Takeuchi, Y. Tanaka, N. Ueda, S. Sekiguchi, et al. “Discovery and Preclinical Profile of Teneligliptin (3-[(2S,4S)-4-[4-(3-Methyl-1-Phenyl-1H-Pyrazol-5-yl)Piperazin-1-yl]Pyrrolidin-2-Ylcarbonyl]Thiazolidine): A Highly Potent, Selective, Long-Lasting and Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes,” Bioorganic & Medicinal Chemistry 20, no. 19 (2012): 5705–19. doi:10.1016/j.bmc.2012.08.012.
   PubMed Web of Science ®Google Scholar
• A. Karmakar, M. Basha, G. Babu, M. Botlagunta, N. Malik, R. Rampulla, A. Mathur, and A. Gupta, “Tertiary-Butoxycarbonyl (Boc)-A Strategic Group for N-Protection/Deprotection in the Synthesis of Various Natural/Unnatural N-Unprotected Aminoacid Cyanomethyl Esters,” Tetrahedron Letters 59, no. 48 (2018): 4267–71. doi:10.1016/j.tetlet.2018.10.041.
   Web of Science ®Google Scholar
• O. Bekircan and H. Bektas, “Synthesis of Schiff and Mannich Bases of Isatin Derivatives with 4-Amino-4,5-Dihydro-1H-1,2,4-Triazole-5-Ones,” Molecules (Basel, Switzerland) 13, no. 9 (2008): 2126–35. doi:10.3390/molecules13092126.
   PubMed Web of Science ®Google Scholar
• H. Jiyaul, S. Vandana, C. Dheeraj, L. Hassane, and Q. Mumtaz, “Microwave-Induced Synthesis of Chitosan Schiff Bases and Their Application as Novel and Green Corrosion Inhibitors, Experimental and Theoretical Approach,” ACS Omega 3 (2018): 5654–68.
   PubMed Web of Science ®Google Scholar
• K. Campbell, C. Helbing, M. Florkowsk, and B. Campbell, “The Reaction of Grignard Reagents with Schiff Bases,” Journal of the American Chemical Society 70, no. 11 (1948): 3868–70. doi:10.1021/ja01191a099.
   PubMed Web of Science ®Google Scholar
• S. Magaldi, C. Mata-Essayag, C. Capriles, C. Perez, M. Colella, C. Olaizola, and Y. Ontiveros, “Well Diffusion for Antifungal Susceptibility Testing,” International Journal of Infectious Diseases 8, no. 1 (2004): 39–45. doi:10.1016/j.ijid.2003.03.002.
   PubMed Web of Science ®Google Scholar
• M. Ahmed, “Acute Toxicity (Lethal Dose 50 Calculation) of Herbal Drug Somina in Rats and Mice,” Pharmacology & Pharmacy 06, no. 03 (2015): 185–9. doi:10.4236/pp.2015.63019.
   Google Scholar
• S. Zhang, Y. Luo, L. He, Z. Liu, A. Jiang, Y. Yang, and H. Zhu, “Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1,3,4-Oxadiazole Derivatives Possessing Benzotriazole Moiety as FAK Inhibitors with Anticancer Activity,” Bioorganic & Medicinal Chemistry 21, no. 13 (2013): 3723–9. doi:10.1016/j.bmc.2013.04.043.
   PubMed Web of Science ®Google Scholar
• A. Pund, M. Shaikh, B. Chandak, V. Bhosale, and B. Magare, “Pyridine-1,3,4-Thiadiazole-Schiff Base Derivatives, as Antioxidant and Antimitotic Agent: Synthesis and in Silico ADME Studies,” Polycyclic Aromatic Compounds (2022): 1–6. doi:10.1080/10406638.2022.2026988.
   Google Scholar